INTERNATIONAL PATENT: GENENTECH, INC., HOFFMANN-LA ROCHE INC., F. HOFFMANN-LA ROCHE AG, PFIZER INC. FILES APPLICATION FOR "METHODS FOR TREATMENT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS WITH AN ANTI-TL1A ANTIBODY"

GENEVA, April 8 -- GENENTECH, INC. (1 Dna WaySouth San Francisco, CA 94080-4990), HOFFMANN-LA ROCHE INC. (150 Clove Road, Overlook At Great Notch, Suite 8Little Falls, NJ 07424), F. HOFFMANN-LA ROCHE AG (Grenzacherstrasse 1244070 Basel), PFIZER INC. (66 Hudson Boulevard EastNew York, NY 10001-2192) filed a patent application (PCT/US2025/048233) for "METHODS FOR TREATMENT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS WITH AN ANTI-TL1A ANTIBODY" on Sep 26, 2025. With publication no. WO/2026/072993, the details related to the patent application was published on Apr 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organi...